Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 160,341 | 171,955 | 167,466 | 169,411 | 157,991 |
| Cost of Goods | 49,020 | 61,916 | 50,678 | 50,627 | 36,074 |
| Gross Profit | 111,321 | 110,039 | 116,788 | 118,784 | 121,917 |
| Operating Expenses | 114,432 | 120,848 | 96,177 | 88,176 | 104,598 |
| Operating Income | -3,091 | -9,893 | 21,289 | 31,235 | 17,393 |
| Interest Expense | 9,589 | 11,041 | 9,856 | 8,833 | 10,246 |
| Other Income | -13,794 | 2,866 | -9,364 | -395 | 147 |
| Pre-tax Income | -26,474 | -18,068 | 2,069 | 22,007 | 7,294 |
| Income Tax | -6,938 | -7,966 | 2,762 | 2,131 | 466 |
| Net Income Continuous | -19,536 | -10,102 | -693 | 19,876 | 6,828 |
| Net Income | $-19,536 | $-10,102 | $-693 | $19,876 | $6,828 |
| EPS Basic Total Ops | -0.43 | -0.22 | -0.02 | 0.44 | 0.15 |
| EPS Basic Continuous Ops | -0.43 | -0.22 | -0.02 | 0.44 | 0.15 |
| EPS Diluted Total Ops | -0.43 | -0.19 | -0.02 | 0.40 | 0.15 |
| EPS Diluted Continuous Ops | -0.43 | -0.17 | -0.02 | 0.38 | 0.15 |
| EBITDA(a) | $18,123 | $22,656 | $43,086 | $53,679 | $39,311 |